{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:26:04Z","timestamp":1761488764672},"reference-count":25,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":3605,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Changes in body fat distribution and abnormal glucose metabolism are common in HIV-infected patients. We hypothesized that HIV-infected participants would have a higher prevalence of impaired glucose tolerance (IGT) compared with control subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A total of 491 HIV-infected and 187 control participants from the second examination of the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM) underwent glucose tolerance testing (GTT). Multivariable regression was used to identify factors associated with GTT parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The prevalence of impaired fasting glucose (IFG) (&amp;gt;110 mg\/dL) was similar in HIV-infected and control participants (21 vs. 25%, P = 0.23). In those without IFG, the prevalence of IGT was slightly higher in HIV-infected participants compared with control subjects (13.1 vs. 8.2%, P = 0.14) and in HIV+ participants with lipoatrophy versus without (18.1 vs. 11.5%, P = 0.084). Diabetes detected by GTT was rare (HIV subjects 1.3% and control subjects 0%, P = 0.65). Mean 2-h glucose levels were 7.6 mg\/dL higher in the HIV-infected participants (P = 0.012). Increased upper trunk subcutaneous adipose tissue (SAT) and decreased leg SAT were associated with 2-h glucose and IGT in both HIV-infected and control participants. Adjusting for adipose tissue reduced the estimated effects of HIV. Exercise, alcohol use, and current tenofovir use were associated with lower 2-h glucose levels in HIV-infected participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>In HIV infection, increased upper trunk SAT and decreased leg SAT are associated with higher 2-h glucose. These body fat characteristics may identify HIV-infected patients with normal fasting glucose but nonetheless at increased risk for diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc11-0616","type":"journal-article","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T04:32:22Z","timestamp":1316233942000},"page":"2448-2453","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":7,"title":["Association of Increased Upper Trunk and Decreased Leg Fat With 2-h Glucose in Control and HIV-Infected Persons"],"prefix":"10.2337","volume":"34","author":[{"given":"Lisa A.","family":"Kosmiski","sequence":"first","affiliation":[{"name":"University of Colorado, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, California"},{"name":"Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven B.","family":"Heymsfield","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center, Baton Rouge, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Rimland","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Veterans Affairs Medical Center, and Emory University School of Medicine, Decatur, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Simberkoff","sequence":"additional","affiliation":[{"name":"Department of Medicine, Veterans Affairs Medical Center New York Harbor Healthcare System and New York University School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sidney","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, California"},{"name":"Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bacchetti","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Biggs","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Grunfeld","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, California"},{"name":"Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2011,10,15]]},"reference":[{"key":"2022031220015269900_B1"},{"key":"2022031220015269900_B2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4314\/eamj.v85i1.9600","article-title":"Prevalence of dyslipidemia and dysglycaemia in HIV infected patients","volume":"85","author":"Manuthu","year":"2008","journal-title":"East Afr Med J"},{"key":"2022031220015269900_B3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1468-1293.2006.00398.x","article-title":"Abnormal glucose metabolism among older men with or at risk of HIV infection","volume":"7","author":"Howard","year":"2006","journal-title":"HIV Med"},{"key":"2022031220015269900_B4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e318158c0a6","article-title":"Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy","volume":"46","author":"Mutimura","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022031220015269900_B5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/diacare.28.1.132","article-title":"Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors","volume":"28","author":"Jeric\u00f3","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031220015269900_B6","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1086\/429824","article-title":"Disorders of glucose metabolism among HIV-infected women","volume":"40","author":"Howard","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2022031220015269900_B7","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"2022031220015269900_B8","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"2022031220015269900_B9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/QAI.0b013e31814b94e2","article-title":"Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study","volume":"46","author":"Grunfeld","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022031220015269900_B10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/kwj111","article-title":"The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics","volume":"163","author":"Tien","year":"2006","journal-title":"Am J Epidemiol"},{"key":"2022031220015269900_B11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022031220015269900_B12"},{"key":"2022031220015269900_B13","first-page":"382","article-title":"Bayesian model averaging: a tutorial","volume":"14","author":"Hoeting","year":"1999","journal-title":"Stat Sci"},{"key":"2022031220015269900_B14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096228029900800102","article-title":"Multiple imputation: a primer","volume":"8","author":"Schafer","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"2022031220015269900_B15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32833ac7a2","article-title":"Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy","volume":"24","author":"Grunfeld","year":"2010","journal-title":"AIDS"},{"key":"2022031220015269900_B16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archinte.162.2.209","article-title":"Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study","volume":"162","author":"Smith","year":"2002","journal-title":"Arch Intern Med"},{"key":"2022031220015269900_B17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI118083","article-title":"Relationships of generalized and regional adiposity to insulin sensitivity in men","volume":"96","author":"Abate","year":"1995","journal-title":"J Clin Invest"},{"key":"2022031220015269900_B18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0026-0495(99)90033-1","article-title":"Insulin sensitivity and serum triglyceride level in obese white and black women: relationship to visceral and truncal subcutaneous fat","volume":"48","author":"Marcus","year":"1999","journal-title":"Metabolism"},{"key":"2022031220015269900_B19","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1210\/jc.2009-0980","article-title":"Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men","volume":"94","author":"Frederiksen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031220015269900_B20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00125-004-1637-7","article-title":"Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study","volume":"48","author":"Snijder","year":"2005","journal-title":"Diabetologia"},{"key":"2022031220015269900_B21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diacare.27.2.372","article-title":"Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study","volume":"27","author":"Snijder","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031220015269900_B22","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/jac\/dkp100","article-title":"Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen","volume":"63","author":"Gerschenson","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"2022031220015269900_B23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"2022031220015269900_B24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/QAD.0b013e328333af1c","article-title":"The protease inhibitor combination lopinavir\/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers","volume":"24","author":"Pao","year":"2010","journal-title":"AIDS"},{"key":"2022031220015269900_B25","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/11\/2448\/606745\/2448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/11\/2448\/606745\/2448.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:49:18Z","timestamp":1647121758000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/34\/11\/2448\/28819\/Association-of-Increased-Upper-Trunk-and-Decreased"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,15]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,10,15]]},"published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc11-0616","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2011,10,15]]}}}